Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Nimit Mehta, Bhumika Aggarwal, Jaideep Gogtay & Sabeer Abdool-Gaffar. (2015) Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma. Expert Opinion on Drug Delivery 12:6, pages 963-975.
Read now
Read now
Marci Clark, Susan Martin, Henrik Svedsater, Peter Dale & Loretta Jacques. (2015) Measurement properties of an asthma symptom and rescue medication use diary. Journal of Asthma 52:1, pages 88-97.
Read now
Read now
Anna Bodzenta-Lukaszyk, Roland Buhl, Beatrix Balint, Mark Lomax, Kay Spooner & Sanjeeva Dissanayake. (2012) Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety. Journal of Asthma 49:10, pages 1060-1070.
Read now
Read now
Dennis Kim, Mark Glaum & Richard Lockey. (2009) Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 933-940.
Read now
Read now
Steven W. Yancey, Michael Klotsman, Hector G. Ortega, Lisa D. Edwards & Wayne H. Anderson. (2009) Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β2-adrenergic polymorphisms. Current Medical Research and Opinion 25:4, pages 1011-1018.
Read now
Read now
William E Berger. (2008) New approaches to managing asthma: a US perspective
. Therapeutics and Clinical Risk Management 4:2, pages 363-379.
Read now
Read now
Articles from other publishers (33)
Kamini, Anoop Kumar, Pooja A. Chawla & Bhupinder Kapoor. 2023. Recent Developments in Anti-Inflammatory Therapy. Recent Developments in Anti-Inflammatory Therapy
331
386
.
Oliver Kornmann, Janos Mucsi, Nadezda Kolosa, Lorraine Bandelli, Biswajit Sen, Lisa C. Satlin & Peter D'Andrea. (2020) Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings. Respiratory Medicine 161, pages 105809.
Crossref
Crossref
Christopher J Cates, Stefanie Schmidt, Montse Ferrer, Ben Sayer & Samuel Waterson. (2018) Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Taro Kunitomi, Masayuki Hashiguchi & Mayumi Mochizuki. (2016) Application of Indirect Comparison to the Drug Development Process: Forecasting Direct Comparison Study Results. The Journal of Clinical Pharmacology 56:9, pages 1165-1170.
Crossref
Crossref
Bhupendrasinh F Chauhan, Caroline Chartrand, Muireann Ni Chroinin, Stephen J Milan & Francine M Ducharme. (2015)
Addition of long-acting beta
2
-agonists to inhaled corticosteroids for chronic asthma in children
. Cochrane Database of Systematic Reviews 2015:11.
Crossref
Crossref
Huib A M Kerstjens, Thomas B Casale, Eugene R Bleecker, Eli O Meltzer, Emilio Pizzichini, Olaf Schmidt, Michael Engel, Loek Bour, Cynthia B Verkleij, Petra Moroni-Zentgraf & Eric D Bateman. (2015) Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. The Lancet Respiratory Medicine 3:5, pages 367-376.
Crossref
Crossref
Taro Kunitomi, Masayuki Hashiguchi & Mayumi Mochizuki. (2015) Effect of Common Comparators in Indirect Comparison Analysis of the Effectiveness of Different Inhaled Corticosteroids in the Treatment of Asthma. PLOS ONE 10:3, pages e0120836.
Crossref
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Riccardo Polosa, Gabriella Papale & Stephen T HolgateWilliam E Berger. 2012. Advances in Asthma Management. Advances in Asthma Management
54
64
.
Anna Bodzenta-Lukaszyk, Andrzej Dymek, Kirsten McAulay & Heikki Mansikka. (2011) Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
Dirkje S. Postma, Paul M. O'Byrne & Søren Pedersen. (2011) Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control. Chest 139:2, pages 311-318.
Crossref
Crossref
Muireann Ni Chroinin, Toby J Lasserson, Ilana Greenstone & Francine M Ducharme. (2010) Cochrane Review: Addition of long‐acting beta‐agonists to inhaled corticosteroids for chronic asthma in children. Evidence-Based Child Health: A Cochrane Review Journal 5:2, pages 796-956.
Crossref
Crossref
Christian Frois, Eric Q. Wu, Saurabh Ray & Gene L. Colice. (2009) Inhaled corticosteroids or long-acting β-agonists alone or in fixed-dose combinations in asthma treatment: A systematic review of fluticasone/budesonide and formoterol/salmeterol. Clinical Therapeutics 31:12, pages 2779-2803.
Crossref
Crossref
Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson & Francine M Ducharme. (2009) Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kate McKeage & Susan J. Keam. (2009) Salmeterol/Fluticasone Propionate. Drugs 69:13, pages 1799-1828.
Crossref
Crossref
Muireann Ni Chroinin, Toby J Lasserson, Ilana Greenstone & Francine M Ducharme. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Timothy P YorkCristina Vargas-IrwinWayne H Anderson & Edwin JCG van den Oord. (2009) Asthma pharmacogenetic study using finite mixture models to handle drug-response heterogeneity. Pharmacogenomics 10:5, pages 753-767.
Crossref
Crossref
Heather M. Edin, Leslie B. Andersen, Lynne Schoaf, Catherine A. Scott-Wilson, Shu-Yen Ho & Hector G. Ortega. (2009) Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. Annals of Allergy, Asthma & Immunology 102:4, pages 323-327.
Crossref
Crossref
Gustavo J. Rodrigo, Vicente Plaza Moral, Luis García Marcos & José A. Castro-Rodriguez. (2009) Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Pulmonary Pharmacology & Therapeutics 22:1, pages 9-19.
Crossref
Crossref
Nick P Adams, Janine C Bestall, Toby J Lasserson, Paul Jones & Christopher J Cates. (2008) Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Christopher J Cates & Matthew J Cates. (2008) Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Alyn H. Morice, Lude˘k Hochmuth, Jan Ekelund, Anders Thorén & Allan S. Puterman. (2008) Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler® in adolescents and adults with asthma. Pulmonary Pharmacology & Therapeutics 21:1, pages 32-39.
Crossref
Crossref
&NA;. (2007) Inhaled salmeterol/fluticasone propionate: a guide to its use in asthma. Drugs & Therapy Perspectives 23:11, pages 1-4.
Crossref
Crossref
N.C. Barnes, L. Jacques, C. Goldfrad & E.D. Bateman. (2007) Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100μg bd versus fluticasone propionate 100μg bd alone in patients with persistent asthma: Integrated analysis of four randomised trials. Respiratory Medicine 101:11, pages 2358-2365.
Crossref
Crossref
Robert L. Cowie, Louis-Philippe Boulet, Paul K. Keith, Catherine A. Scott-Wilson, Karen W. House & Paul M. Dorinsky. (2007) Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study. Clinical Therapeutics 29:7, pages 1390-1402.
Crossref
Crossref
Jonathan Corren, Phillip E. Korenblat, Christopher J. Miller, Christopher D. O'Brien & William S. Mezzanotte. (2007) Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clinical Therapeutics 29:5, pages 823-843.
Crossref
Crossref
Michael J Perrio, Lynda V Wilton & Saad A W Shakir. (2007) A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler??? in England. Drug Safety 30:8, pages 681-695.
Crossref
Crossref
Paul M O'Byrne & Krishnan Parameswaran. (2006) Pharmacological management of mild or moderate persistent asthma. The Lancet 368:9537, pages 794-803.
Crossref
Crossref
. (2006) Current World Literature. Current Opinion in Allergy & Clinical Immunology 6:3, pages 241-248.
Crossref
Crossref
Robert A. Nathan, Anthony Rooklin, Lynne Schoaf, Catherine Scott, Anna Ellsworth, Karen House & Paul Dorinsky. (2006) Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Clinical Therapeutics 28:1, pages 73-85.
Crossref
Crossref
NP Adams, JC Bestall, TJ Lasserson, PW Jones & CJ Cates. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:7, pages i-xii.
Crossref
Crossref